Royal Bank Of Canada Lyra Therapeutics, Inc. Transaction History
Royal Bank Of Canada
- $471 Billion
- Q3 2024
A detailed history of Royal Bank Of Canada transactions in Lyra Therapeutics, Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 6,171 shares of LYRA stock, worth $1,234. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,171
Previous 4,873
26.64%
Holding current value
$1,234
Previous $1,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding LYRA
# of Institutions
60Shares Held
32.2MCall Options Held
21.1KPut Options Held
400-
Perceptive Advisors LLC New York, NY12.8MShares$2.55 Million0.09% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il4.77MShares$954,5630.0% of portfolio
-
Black Rock Inc. New York, NY2.83MShares$565,9950.0% of portfolio
-
Samsara Bio Capital, LLC Palo Alto, CA2.78MShares$556,0520.42% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.78MShares$355,8520.0% of portfolio
About Lyra Therapeutics, Inc.
- Ticker LYRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 31,826,400
- Market Cap $6.37M
- Description
- Lyra Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. It's XTreo technology platform is designed to deliver medicines directly to the affected tissue for sustained...